Mittal Jyoti, Kaur Gurpreet, Mann Harmunish S, Narang Samisha, Kamra Mohit, Kapoor Shekhar, Sindhi Madhu, Kataria Ramneet
Department of Oral and Maxillofacial Surgery, Shaheed Kartar Singh Sarabha Dental College & Hospital, Ludhiana, Punjab India, Phone: +918437120001, e-mail:
Department of Dental, Mohandai Oswal Hospital, Ludhiana Punjab, India.
J Contemp Dent Pract. 2018 Jun 1;19(6):743-748.
The aim of this study was to evaluate the safety and efficacy of 4% articaine with epinephrine (1:200,000) vs 2% lidocaine with epinephrine (1:200,000) during surgical removal of impacted mandibular third molars.
The present study was undertaken in 20 patients belonging to American Society of Anesthesiologists (ASA) class I, of the age group between 18 and 30 years with bilaterally impacted mandibular third molars. Each patient underwent similar surgical procedure. In the first appointment, the patient was randomly selected to receive either 4% articaine or 2% lidocaine (both with epinephrine 1:200,000). Intraoperative and postoperative evaluation was done for both the anesthetic solutions. Following parameters were evaluated: total volume of anesthetic solution used during the surgery, onset of action of the anesthetic agent, duration of anesthesia, duration of postoperative analgesia, incidence, type and severity of adverse reactions, any need to reanesthetize the surgical zone and quality of anesthesia provided by the local anesthetic. Subjective pain evaluation was done with the aid of 100 mm length visual analog scale (VAS) both intraoperatively and postoperatively.
In the present study, 4% articaine was found to have a significantly shorter onset of action than 2% lidocaine. Duration of anesthesia and postoperative analgesia of 4% articaine with epinephrine 1:200,000 was found to be significantly (1.44 and 1.28 times respectively) longer than 2% lidocaine with epinephrine 1:200,000. But no significant difference was found in other parameters.
4% articaine in comparison with 2% lidocaine (both with epinephrine 1:200,000) provided a shorter onset of action and longer duration of anesthesia.
No significant difference was recorded in the anesthetic efficacy between the two solutions.
本研究旨在评估在拔除下颌阻生第三磨牙手术中,4%阿替卡因加肾上腺素(1:200,000)与2%利多卡因加肾上腺素(1:200,000)的安全性和有效性。
本研究纳入20例美国麻醉医师协会(ASA)I级、年龄在18至30岁之间、双侧下颌阻生第三磨牙的患者。每位患者均接受类似的手术操作。在首次就诊时,患者被随机选择接受4%阿替卡因或2%利多卡因(均加肾上腺素1:200,000)。对两种麻醉溶液进行术中及术后评估。评估以下参数:手术期间使用的麻醉溶液总量、麻醉剂的起效时间、麻醉持续时间、术后镇痛持续时间、不良反应的发生率、类型和严重程度、是否需要对手术区域再次麻醉以及局部麻醉提供的麻醉质量。术中及术后借助100毫米长的视觉模拟量表(VAS)进行主观疼痛评估。
在本研究中,发现4%阿替卡因的起效时间明显短于2%利多卡因。发现4%阿替卡因加肾上腺素1:200,000的麻醉持续时间和术后镇痛持续时间分别比2%利多卡因加肾上腺素1:200,000显著长(分别为1.44倍和1.28倍)。但在其他参数方面未发现显著差异。
与2%利多卡因(均加肾上腺素1:200,000)相比,4%阿替卡因起效时间更短,麻醉持续时间更长。
两种溶液在麻醉效果上未记录到显著差异。